(Rana Healthcare Solutions LLC) Shimmer, a global leader in wearable technology for research applications, today launched Verisense™, its next-generation wearable sensor platform designed from the ground up to meet the needs of clinical trial sponsors, sites and participants. Verisense is a comprehensive and flexible solution for reliably capturing accurate and complete biometric data. Starting in March, Shimmer customers are planning to use Verisense in trials for Alzheimer’s disease, Parkinson’s disease, cancer-related fatigue, and stroke.

Original source: https://www.eurekalert.org/pub_releases/2019-02/rhsl-slv021419.php